ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32513-100mg |
|
547-44-4 |
Sulfacarbamide
|
0 | C7H9N3O3S | |
GC32513-10mM(1mLinDMSO) |
|
547-44-4 |
Sulfacarbamide
|
0 | C7H9N3O3S | |
GC32512-20mg |
|
85392-79-6 |
Indanidine
|
0 | C11H13N5 | |
GC32512-10mg |
|
85392-79-6 |
Indanidine
|
0 | C11H13N5 | |
GC32512-5mg |
|
85392-79-6 |
Indanidine
|
0 | C11H13N5 | |
GC32512-1mg |
|
85392-79-6 |
Indanidine
|
0 | C11H13N5 | |
GC32511-100mg |
|
4 |
Naftidrofuryl oxalate (Nafronyl oxalate salt)
|
0 | C26H35NO7 | |
GC32511-10mM(1mLinDMSO) |
|
4 |
Naftidrofuryl oxalate (Nafronyl oxalate salt)
|
0 | C26H35NO7 | |
GC32510-5mg |
|
119425-89-7 |
Loureirin A
|
0 | C17H18O4 | |
GC32510-10mM(1mLinDMSO) |
|
119425-89-7 |
Loureirin A
|
0 | C17H18O4 | |
GC32509-50mg |
|
668463-35-2 |
RPR-260243
|
0 | C28H25F3N2O4 | |
GC32509-10mg |
|
668463-35-2 |
RPR-260243
|
0 | C28H25F3N2O4 | |
GC32509-5mg |
|
668463-35-2 |
RPR-260243
|
0 | C28H25F3N2O4 | |
GC32509-2mg |
|
668463-35-2 |
RPR-260243
|
0 | C28H25F3N2O4 | |
GC32509-10mM(1mLinDMSO) |
|
668463-35-2 |
RPR-260243
|
0 | C28H25F3N2O4 | |
GC32508-100mg |
|
504-03-0 |
Nanofin (2,6-Lupetidine)
|
0 | C7H15N | |
GC32508-10mM(1mLinDMSO) |
|
504-03-0 |
Nanofin (2,6-Lupetidine)
|
0 | C7H15N | |
GC32507-10mg |
|
145733-36-4 |
Tasosartan (WAY-ANA 756)
|
0 | C23H21N7O | |
GC32507-5mg |
|
145733-36-4 |
Tasosartan (WAY-ANA 756)
|
0 | C23H21N7O | |
GC32507-10mM(1mLinDMSO) |
|
145733-36-4 |
Tasosartan (WAY-ANA 756)
|
0 | C23H21N7O | |